Is Individual Operator Experience Important in TAVR?

Courtesy of Dr. Carlos Fava.

Transcatheter aortic valve replacement (TAVR) has emerged as a successful alternative for inoperable patients and a non-inferior alternative for high- and intermediate-risk patients. While its evolution depending on site experience has been analyzed, there is currently very little information regarding the impact of operator individual experience.

Terapia endovascular en stroke: mucha evidencia y pocos operadores entrenadosThis study analyzed 8771 procedures performed by 207 different operators. High-volume operators were defined as those performing ≥80 procedures/year; intermediate-volume operators were those performing between 24 and 79 procedures/year, and low-volume operators, <24 procedures/year. The “learning curve” of these operators was excluded so as to mitigate the incidence of complications that could bias results.

 

Patients of high-volume operators had a significantly lower in-hospital risk for death, stroke, and acute myocardial infarction (odds ratio: 0.59; 95% confidence interval [CI]: 0.37 to 0.93) compared with low-volume operators.


Read also: PCI Mortality and Volume in One Center: Associated?


Patients of operators who performed >200 procedures during the prior year had a significantly lower risk for post-procedural stroke (odds ratio: 0.41; 95% confidence interval: 0.17 to 0.97) and less in-hospital events (odds ratio: 0.45; 95% confidence interval: 0.26 to 0.78).

 

Conclusion

Increased operator experience is associated with improvement in risk-adjusted in-hospital progress. These results are potentially important for individual training and hospital programs in TAVR.

 

Courtesy of Dr. Carlos Fava.

 

Original title: Individual Operator Experience and Outcomes in Transcatheter Aortic Valve Replacement.

Reference: Arash Salemi et al. Article in press.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

TCT 2024 | TRISCEND II

This randomized study included 400 patients; 267 were treated with EVOQUE valve and 133 with optimal medical treatment (OMT). After one-year follow-up, there were no...

TCT 2024 – ACCESS-TAVI: Comparing Percutaneous Access Closure Strategies After TAVI

Vascular access complications following transcatheter aortic valve implantation (TAVI) remain common. However, few studies compare vascular access closure methods.  Based on the CHOICE-CLOSURE and MASH...

TAVR in Young Low-Risk Patients

Transcatheter aortic valve replacement (TAVR) has established itself as an effective strategy for the treatment of severe aortic stenosis across different risk groups. While previous...

TAVR and Atrial Fibrillation: What Anticoagulants Should We Use?

The prevalence of atrial fibrillation (AF) in TAVR patients ranges from 15 to 30%, depending on series. This arrhythmia has been associated to higher...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 | TRISCEND II

This randomized study included 400 patients; 267 were treated with EVOQUE valve and 133 with optimal medical treatment (OMT). After one-year follow-up, there were no...

TCT 2024 – ACCESS-TAVI: Comparing Percutaneous Access Closure Strategies After TAVI

Vascular access complications following transcatheter aortic valve implantation (TAVI) remain common. However, few studies compare vascular access closure methods.  Based on the CHOICE-CLOSURE and MASH...